Cath Lab

The cardiac catheterization laboratory is used for diagnostic angiograms and percutaneous coronary interventions (PCI). Cath labs have also seen expanding use in recent years for transcatheter structural heart procedures. Some hospitals also share these labs with other subspecialties for catheter-based procedures in electrophysiology (EP), interventional radiology, peripheral artery disease (PAD), carotid and neuro interventional procedures and vascular surgery.

Part of the cath lab case report from Fujifilm Synapse Cardiovascular. This CVIS was ranked Best in KLAS in 2022 based on user interviews.

Best of KLAS 2022: The top cardiovascular information systems and hemodynamic solutions

KLAS Research released its 2022 Best in KLAS report, which includes cardiovascular information systems and hemodynamic systems. 

Ticagrelor alone after DAPT lowers bleeding risk among heart attack patients undergoing PCI

Researchers examined data from the TWILIGHT study to track how different treatment strategies can impact 12-month PCI outcomes. 

New risk score predicts mortality after TEER

Researchers developed the new algorithm by identifying eight key factors associated with mortality among TEER patients. 

The Bard Venovo venous stent

Office-based cath lab setting proves safe for iliac vein stenting

Iliac vein stunting procedures performed in out-patient office-based labs are associated with low complication rates.

Polymer-free amphilimus-eluting stents comparable to drug-eluting stents—and offer a potential advantage

The team's evaluation included data from four different randomized controlled trials

The Corvia Atrial Shunt is designed to address elevated left atrial pressure (LAP) heart failure patients.

Implantable atrial shunt therapy trial identifies treatable HFpEF patients

The REDUCE LAP-HF II study identified heart failure patients who may benefit from receiving a new transcatheter implant manufactured by Corvia Medical.

Continued anticoagulation after primary PCI boosts survival among STEMI patients

A key takeaway from the group's analysis was that the rate of major bleeding events did not significantly change. 

IVUS guidance during DES implantation boosts long-term outcomes

Researchers focused on data from two previous trials to track the impact of IVUS guidance on mortality rates and other key outcomes after three years. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.